Ritonavir-induced Cushing's syndrome in a patient treated with nasal fluticasone

被引：36

作者：

Hillebrand-Haverkort, ME

Prummel, MF

ten Veen, JH

机构：

[1] Onze Lieve Vrouwe Gasthuis, Dept Med, NL-1017 JZ Amsterdam, Netherlands

[2] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol, NL-1105 AZ Amsterdam, Netherlands

来源：

AIDS | 1999年 / 13卷 / 13期

关键词：

D O I：

10.1097/00002030-199909100-00038

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1803 / 1803

页数：1

共 5 条

[1]

CHEN F, 1998, 4 INT C DRUG THER HI, P159

[2] Lesson of the week - Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions [J].

Findlay, CA ;

Macdonald, JF ;

Wallace, AM ;

Geddes, N ;

Donaldson, MDC .

BRITISH MEDICAL JOURNAL, 1998, 317 (7160) :739-740

[3] Pharmacokinetics and bioavailability of intranasal fluticasone in humans [J].

McDowall, JE ;

Mackie, AE ;

Ventresca, GP ;

Bye, A .

CLINICAL DRUG INVESTIGATION, 1997, 14 (01) :44-52

[4]

Meibohm B, 1998, REV CONTEMP PHARMACO, V9, P535

[5] Protease inhibitors as inhibitors of human cytochromes P450: High risk associated with ritonavir [J].

von Moltke, LL ;

Greenblatt, DJ ;

Grassi, JM ;

Granda, BW ;

Duan, SX ;

Fogelman, SM ;

Daily, JP ;

Harmatz, JS ;

Shader, RI .

JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (02) :106-111

← 1 →